Found 66 matching trials
Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors PHASE4 Inhibition of dipeptidyl peptidase-4 (DPP-4) or sodium-glucose co-transport...
Show More Location
Kurume University Hospital
Learn More & Join Trial
Effects of Empagliflozin in Reducing Oxidative Stress After Kidney Transplantation NA The purpose of this study is to investigate the effect of empagliflozin on ...
Show More Location
Labbafinezhd Hospital
Learn More & Join Trial
Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study PHASE2 Syndrome of inappropriate antidiuresis (SIADH) is characterized by an imbal...
Show More Location
University Hospital Basel
Learn More & Join Trial
Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial PHASE2 This study aims to provide essential mechanistic insights into natriuretic ...
Show More Location
Renal Physiology Laboratory
Learn More & Join Trial
Empagliflozin and Hepatic Glucose Metabolism PHASE4 the aim of this study is to examine the role of autonomic nervous system in...
Show More Location
Diabetes Division, UTHSCSA
Learn More & Join Trial
Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D PHASE4 The co-administration of SGLT2 inhibitor and GLP-1 receptor agonist would b...
Show More Location
Multiple Locations
Learn More & Join Trial
The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes PHASE4 Non-Alcoholic Fatty Liver Disease( NAFLD) is common in patients with type 2...
Show More Location
University of Malaya
Learn More & Join Trial
Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass PHASE4 Bariatric surgery is an effective anti-obesity treatment providing durable ...
Show More Location
Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital and University of Bern
Learn More & Join Trial
SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot PHASE1 Obesity is associated with increased cardiometabolic disease risk due, in p...
Show More Location
Vanderbilt University Medical Center
Learn More & Join Trial
Gemigliptin, Dapagliflozin, Empagliflozin DDI Study PHASE1 gemigliptin,SGLT-2i DDI study...
Learn More & Join Trial